CAH (Cardinal Health, Inc.)
Insider Trading Activity
Every open-market purchase and sale reported by CAH officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-17 | Patricia Hemingway Hall | Director | A | — | — |
| 2026-03-03 | Michelle D. Greene | Chief Information Officer | Sell | — | — |
| 2026-02-18 | Aaron E Alt | Chief Financial Officer | MIXED | — | — |
| 2026-02-10 | Patricia Hemingway Hall | Director | Sell | — | — |
| 2026-01-20 | Valerie Christine Pitteroff | Chief Human Resources Officer | A | — | — |
| 2025-12-02 | Ola M Snow | Chief Human Resources Officer | F | — | — |
| 2025-12-02 | Stephen M Mason | CEO, GMPD Segment | F | — | — |
| 2025-12-02 | Mary C. Scherer | Chief Accounting Officer | F | — | — |
| 2025-12-02 | DEBORAH WEITZMAN | CEO, PSS Segment | F | — | — |
| 2025-12-02 | Jessica L Mayer | Chief Legal/Compliance Officer | F | — | — |
| 2025-11-06 | Robert Azelby | Director | A | — | — |
| 2025-11-06 | Michelle Brennan | Director | A | — | — |
| 2025-11-06 | Sheri H. Edison | Director | A | — | — |
| 2025-11-06 | David C Evans | Director | A | — | — |
| 2025-11-06 | Patricia Hemingway Hall | Director | A | — | — |
| 2025-11-06 | AKHIL JOHRI | Director | A | — | — |
| 2025-11-06 | GREGORY B KENNY | Director | A | — | — |
| 2025-11-06 | Nancy Killefer | Director | A | — | — |
| 2025-11-06 | CHRISTINE MUNDKUR | Director | A | — | — |
| 2025-11-06 | Robert W Musslewhite | Director | A | — | — |
| 2025-11-06 | Sudhakar Ramakrishna | Director | A | — | — |
| 2025-08-20 | Jason M. Hollar | Chief Executive Officer | Sell | — | — |
| 2025-08-20 | DEBORAH WEITZMAN | CEO, PSS Segment | Sell | — | — |
| 2025-08-19 | Ola M Snow | Chief Human Resources Officer | MIXED | — | — |
| 2025-08-19 | Aaron E Alt | Chief Financial Officer | MIXED | — | — |
| 2025-08-19 | Jessica L Mayer | Chief Legal/Compliance Officer | MIXED | — | — |
| 2025-08-19 | Jason M. Hollar | Chief Executive Officer | MIXED | — | — |
| 2025-08-19 | DEBORAH WEITZMAN | CEO, PSS Segment | MIXED | — | — |
| 2025-08-19 | Stephen M Mason | CEO, GMPD Segment | MIXED | — | — |
| 2025-08-19 | Michelle D. Greene | Chief Information Officer | MIXED | — | — |
| 2025-08-19 | Mary C. Scherer | Chief Accounting Officer | MIXED | — | — |
| 2025-08-12 | Aaron E Alt | Chief Financial Officer | A | — | — |
| 2025-08-12 | Jason M. Hollar | Chief Executive Officer | A | — | — |
| 2025-08-12 | Stephen M Mason | CEO, GMPD Segment | A | — | — |
| 2025-08-12 | Jessica L Mayer | Chief Legal/Compliance Officer | A | — | — |
| 2025-08-12 | Mary C. Scherer | Chief Accounting Officer | A | — | — |
| 2025-08-12 | Ola M Snow | Chief Human Resources Officer | A | — | — |
| 2025-08-12 | DEBORAH WEITZMAN | CEO, PSS Segment | A | — | — |
| 2025-08-12 | Michelle D. Greene | Chief Information Officer | A | — | — |
| 2025-06-30 | Ola M Snow | Chief Human Resources Officer | F | — | — |
| 2025-06-30 | Jason M. Hollar | Chief Executive Officer | F | — | — |
| 2025-06-30 | Stephen M Mason | CEO, GMPD Segment | F | — | — |
| 2025-06-30 | Jessica L Mayer | Chief Legal/Compliance Officer | F | — | — |
| 2025-03-18 | Robert W Musslewhite | Director | A | — | — |
| 2025-03-18 | Sudhakar Ramakrishna | Director | A | — | — |
| 2025-02-18 | Michelle D. Greene | Chief Information Officer | F | — | — |
| 2025-02-18 | Aaron E Alt | Chief Financial Officer | F | — | — |
| 2024-12-03 | Ola M Snow | Chief Human Resources Officer | F | — | — |
| 2024-12-03 | Mary C. Scherer | Chief Accounting Officer | F | — | — |
| 2024-12-03 | Jessica L Mayer | Chief Legal/Compliance Officer | F | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Executive Director | 2,264,084 | — |
| — | CEO | 674,760 | — |
| — | Executive Chairman | 502,630 | — |
| — | Former Chairman and CEO | 241,818 | — |
| — | Chief Executive Officer | 200,000 | — |
| — | Director | 166,947 | — |
| — | CEO, Medical Segment | 146,503 | — |
| — | Chief Legal/Compliance Officer | 126,301 | — |
| — | CEO, Medical Segment | 120,577 | — |
| — | CEO, Pharmaceutical Segment | 105,699 | — |
| — | Director | 69,213 | — |
| — | CEO - HSCS | 68,184 | — |
| — | Chief Financial Officer | 67,190 | — |
| — | Director | 64,194 | — |
| — | Vice Chair Cardinal & CEO CTS | 61,898 | — |
| — | CEO, Medical Segment | 61,387 | — |
| — | Director | 53,929 | — |
| — | CEO, PSS Segment | 52,877 | — |
| — | CLO & Secretary | 50,886 | — |
| — | Director | 45,579 | — |
| — | EVP - Strategy & Corp. Dev. | 44,491 | — |
| — | Director | 43,982 | — |
| — | Director | 41,631 | — |
| — | Director | 39,616 | — |
| — | EVP - Corp. Dev. & Strategy | 39,594 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the CAH quote page; the site-wide leaderboard is on the insider transactions hub.